key: cord-0998516-so12r0l2
authors: Purdy, Amanda C.; Hohmann, Samuel F.; Nguyen, Ninh T.
title: Outcomes of Obese Patients Hospitalized with COVID-19: The Impact of Prior Bariatric Surgery
date: 2021-10-05
journal: Surg Obes Relat Dis
DOI: 10.1016/j.soard.2021.08.027
sha: 4859f3a68f68057e49eac05aa0da314dadf3e792
doc_id: 998516
cord_uid: so12r0l2

BACKGROUND: Obesity and several obesity-related comorbidities are risk factors for severe COVID-19 disease. Because bariatric surgery successfully treats obesity-related conditions, we hypothesized that prior bariatric surgery may be associated with less severe COVID-19 disease. OBJECTIVES: To examine the association between prior bariatric surgery and outcomes in patients with obesity admitted with COVID-19 SETTING: United States METHODS: Vizient database was used to obtain demographic and outcomes data for adults with obesity admitted with COVID-19 from May 2020-January 2021. Patients were divided into two groups: those with and those without prior bariatric surgery. The primary outcome was in-hospital mortality. Secondary outcomes were mortality by age, sex, race/ethnicity, and comorbidity, intubation rate, hemodialysis rate, and length of stay (LOS). As the database only provides aggregate data, and not patient-level data, multivariate analysis could not be performed. RESULTS: Among the 124,699 patients with obesity admitted with COVID-19, 2,607 had previous bariatric surgery and 122,092 did not. The proportion of patients >65-years-old was higher in the non-bariatric surgery group (36.0% vs. 27.6%, p<0.0001). Compared to patients without prior bariatric surgery, patients with prior bariatric surgery had lower in-hospital mortality (7.8 vs. 11.2%, p<0.0001) and intubation rates (18.5% vs. 23.6%, p=0.0009). Hemodialysis rate (7.2% vs. 6.9%, p=0.5) and LOS (8.8 vs. 9.6 days, p=0.8) were similar between groups. Mortality was significantly lower in the bariatric surgery group for patients 18-64-years-old (5.9% vs. 7.4%, p=0.01) and >65-years-old (12.9% vs. 17.9%, p=0.0006). CONCLUSIONS: This retrospective cohort study found that inpatients with obesity and COVID-19 who had prior bariatric surgery had improved outcomes compared to a similar cohort without prior bariatric surgery. Further studies should examine mechanisms for the association between bariatric surgery and less severe COVID-19.

Obese patients admitted to the hospital with COVID- 19 Obesity is one of the most common and costly diseases in the United States (US). Over 40% of the adult population has obesity, and prevalence has been increasing over time. (1) Obesity-related conditions, such as type 2 diabetes mellitus (T2D) and heart disease, are some of the leading causes of preventable, premature deaths in the US. While the obesity epidemic has 70 posed a substantial burden to the US healthcare system for decades, 2020 brought on a new magnitude of strain to our healthcare system with the novel coronavirus pandemic. By the end of 2020, COVID-19 became one of the leading causes of deaths in the US. (2) Obesity and many obesity-related comorbidities, such as T2D, heart disease, hypertension, and chronic pulmonary disease, have been associated with increased risk of severe illness and death from COVID-19. (3-75 6) Bariatric surgery is the most effective intervention for patients with morbid obesity to achieve and maintain weight loss. When compared to standard medical therapy alone, bariatric surgery has also been shown to be more effective in improving or even eliminating T2D, hypertension, obstructive sleep apnea, and hyperlipidemia. (7, 8) Because bariatric surgery is so 80 successful in treating these conditions that are also implicated as risk factors for severe COVID-19, it is plausible that a history of bariatric surgery may have a protective effect in patients infected with the novel coronavirus. A nationwide retrospective study from France evaluated patients with obesity admitted with COVID-19 and found that patients with a history of bariatric surgery had significantly lower rates of intubation and mortality. (9) Another study from Italy 85 reported a lower rate of COVID-19 hospitalizations in patients with obesity who had a history of bariatric surgery. (10) A single-institution study in Cleveland found a lower rate of hospital admission in patients with COVID-19 with a history of bariatric surgery. (11) To our knowledge, J o u r n a l P r e -p r o o f 4 there has not been a large-scale study in the US evaluating the association between bariatric surgery history and COVID-19 illness severity. The aim of this study was to compare the 90 characteristics and outcomes of patients with obesity hospitalized with COVID-19 with and without a history of bariatric surgery.

Data were obtained using the Vizient clinical database, which contains data for all 95 inpatients admitted to US academic medical centers that are members of Vizient, as well as their affiliated hospitals. (12) The database reports in-hospital outcomes data, and not post-discharge follow-up data. The data are based on billing records, and include demographics, lengths of stay, and in-hospital mortality rates. Data can be selected according to many criteria, including International Classification of Diseases (ICD) diagnosis and procedure codes. The use of this 100 database was approved by Vizient Inc. This study was considered exempt by the institutional review committee at the University of California, Irvine Medical Center as the database does not contain identifiable patient-level data. Patient informed consent was waived by the institutional review committee.

We obtained demographic and outcomes data for all inpatients with the admission 105 diagnosis of COVID-19 (ICD-10 code U071) and obesity (ICD-10 codes E6609, E6601, E660, E668, E669) from May 1, 2020 to January 31, 2021. The months of March and April 2020 were excluded because during this time, many US hospitals were overwhelmed and had limited resources to treat patients with COVID-19. This is illustrated by the exceedingly high mortality rates during those initial months of the pandemic, followed by more consistent mortality rates 110 beginning in May 2020. (13) In addition, because of the limited testing capabilities in March and J o u r n a l P r e -p r o o f 5 April 2020, COVID-19 diagnoses during that time may not be accurate. Patients less than 18years-old were also excluded. Demographics included sex, age group, race/ethnicity, and comorbidities. The comorbidities evaluated were hypertension, diabetes, chronic pulmonary disease, congestive heart failure, and renal disease. Patients were separated into two groups: the 115 bariatric surgery group included those with a history of bariatric surgery (ICD-10 code Z98.84) and the non-bariatric surgery group included those without a history of bariatric surgery (bariatric surgery status excluded). The primary outcome measure was overall in-hospital mortality. Secondary outcome measures were in-hospital mortality by age, sex, race/ethnicity, and comorbidity, the proportions of patients that required mechanical ventilation and 120 hemodialysis, and mean hospital length of stay (LOS).

Continuous variables were reported as means and standard deviations (SD) and categorical variables were reported as numbers and percentages. Categorical data were compared between groups using Pearson's chi-square test and between-group means were compared using student's t-test. A P-value of less than 0.05 was considered significant. This study followed the 125

Strengthening the Reporting of Observational Studies in Epidemiology reporting guidelines.

There were 124,699 adults with obesity who were admitted with COVID-19 from May 2020 through January 2021. Of these patients, 2,607 (2.1%) had a history of bariatric surgery and 130 122,092 (97.9%) did not. There were significant differences between groups in all demographic categories (Table 1) . Patients admitted for COVID-19 with a history of bariatric surgery were more often female than those without a history of bariatric surgery (72.4% vs. 52.4%, p<0.0001).

The majority of patients with and without a history of bariatric surgery were less than 65-years- Overall in-hospital mortality was significantly lower in patients with a history of bariatric surgery than those without a history of bariatric surgery (7.8% vs. 11.2%, p<0.0001) ( Table 2) .

When examining in-hospital mortality according to age group, patients with a history of bariatric surgery had significantly lower in-hospital mortality rates than those without a history of 150 bariatric surgery for both the 18-64-year age group (5.9% vs. 7.4%, p=0.01) and the >65-year age group (12.9% vs. 17.9%, p=0.0006). In-hospital mortality rates for every race and ethnicity were lower for patients with a history of bariatric surgery, however, this only reached statistical significance in patients who identified as white or black. In-hospital mortality rates according to comorbidity were significantly lower in patients with a history of bariatric surgery compared to 155 those without prior bariatric surgery ( Table 2 ). The rate of mechanical ventilation was significantly higher for the group without prior bariatric surgery compared to the group with 7 prior bariatric surgery (23.6% vs. 18.5%, p<0.0001). There was no significant difference in the rate of patients with obesity admitted with COVID-19 requiring hemodialysis between groups (6.9% for without bariatric surgery vs. 7.2% for with prior bariatric surgery, p=0.5). Hospital 160 LOS did not vary between groups. (Table 2 )

Bariatric surgery is recognized as the most effective intervention for patients with obesity to achieve sustained weight loss and to improve or resolve obesity-related comorbidities. 165

Bariatric surgery is an invaluable tool in combating the obesity epidemic, and we evaluated how these procedures may also play a role in the COVID-19 pandemic. In this retrospective study of 124,699 adults with obesity admitted with COVID-19 at US academic medical centers, those with a history of bariatric surgery had improved outcomes with significantly lower rates of overall in-hospital mortality and mechanical ventilation than patients without a history of 170 bariatric surgery.

The demographics of our bariatric surgery cohort closely mirror national numbers for those who undergo bariatric surgery. We found that 2.1% of patients of patients with obesity admitted with COVID-19 had a history of bariatric surgery, which is similar to reports that approximately 1.1% of patients who qualify for bariatric surgery in the US actually undergo 175 surgery. (14) In addition, a prior systematic review found that approximately 72.6% of patients who underwent bariatric surgery were women, which is almost identical to our finding of 72.4% of women in the bariatric surgery cohort. (7) The systematic review also found that patients undergo bariatric surgery at an average age of 39, which is consistent with our finding that patients in the bariatric surgery cohort were mostly younger than 65-years-old. ( adversely affect outcomes in pulmonary infections. First, obesity leads to several adverse changes in pulmonary physiology, including decreased respiratory compliance, increased airway resistance, increased work of breathing, and less efficient respiration. (16, 17) Patients with obesity may also develop obstructive sleep apnea and/or obesity hypoventilation syndrome, leading to hypoxia and subsequent pulmonary artery hypertension. (16) This suggests that patients with 190 obesity have decreased pulmonary reserve and are more susceptible to severe disease when confronted with pulmonary infections. A prior meta-analysis found that bariatric surgery significantly improved overall pulmonary function scores in patients with morbid obesity. (18) Some hypothesize that increased angiotensin-converting enzyme 2 (ACE2) expression may play a role in increased COVID-19 disease severity in patients with obesity and T2D. ACE2, which 195 has increased expression in patients with obesity and T2D, has been identified as the functional receptor of SARS-CoV-2 and provides the virus entry into human cells. (19) (20) (21) (22) It is possible that patients with prior bariatric surgery have decreased ACE2 expression, leading to improved COVID-19 outcomes. Interestingly, even among patients with comorbidities associated with severe COVID-19 disease, we found that a history of bariatric surgery was independently 200 associated with decreased in-hospital mortality. This could be because the obesity-related comorbidities may be less severe in the bariatric surgery cohort. Another possible explanation is that bariatric surgery has been proven to decrease systemic markers of inflammation, including J o u r n a l P r e -p r o o f 9 interleukin-6 and tumor necrosis factor-. (23) These inflammatory markers are also involved in the damage caused by the COVID-19 "cytokine storm," and levels are increased in patients with 205 more severe disease. (22) Unfortunately, when the COVID-19 pandemic began ramping up in the US, patients' access to bariatric surgery quickly came to a halt. On March 13 th , 2020, the American College of Surgeons recommended postponing elective operations in response to the anticipated COVID-19 surge in order to conserve hospital resources and to protect patients and personnel. (24) The delay 210 of bariatric surgery that happened as a result will undoubtedly result in a substantial burden of disease in patients who would have been bariatric surgical candidates. Bariatric surgery has many proven benefits, including the treatment of obesity and its related conditions, reducing cancer risk, and several studies on all-cause mortality have found that patients who have had bariatric surgery live longer than matched patients without a history of bariatric surgery. (25) We 215 now show, similarly to a French database study, that a history of bariatric surgery is associated with lower rates of in-hospital mortality and intubation in patients hospitalized with COVID-19, further highlighting the important role of bariatric surgery. (9) While classified as elective surgeries, bariatric operations have significant implications for controlling diseases that cause substantial burden to our patients and healthcare system. These operations should be classified as 220 time-sensitive, as delaying bariatric surgery is associated with lower T2D remission rates. (25) Unfortunately, it has been reported that at the height of the pandemic in the US, bariatric operative volume was reduced by 98%. (26) As hospitals and surgeons start to tackle the backlog of operations that were delayed during the pandemic, bariatric surgeries should be given strong consideration for prioritization. 225 J o u r n a l P r e -p r o o f 10 There are several limitations to this study. As a retrospective database study, there is an intrinsic risk for selection bias and ICD coding errors. In addition, the database is limited to reporting in-hospital mortality only. Therefore, our results may under-report overall mortality.

Also, while the database allowed us to determine in-hospital mortality by comorbidity, it did not provide information on the severity of each comorbidity. This information could have been 230 helpful in determining why in-hospital mortality and intubation rates were lower in the bariatric surgery group. Another limitation is that the database does not provide patient-level data, precluding multivariate analysis. It is notable that the non-bariatric surgery cohort had a higher proportion of patients in the >65 age group than the bariatric surgery cohort, which could lead to overestimating the overall mortality of the non-bariatric surgery group. However, it is important 235

to note that mortality rates in the bariatric surgery group were significantly lower for patients in both the 18-64 and >65 age groups. In addition, this study only examined COVID-19 patients that were sick enough to require hospitalization and our data cannot be extrapolated to patients managed in the outpatient setting. However, other studies from Italy and Cleveland found decreased rates of hospital admission in patients with COVID-19 who had a history of bariatric 240 surgery, further suggesting that a history of bariatric surgery is associated with less severe COVID-19 disease. (10, 11) Despite these limitations, this study is the largest to date examining a cohort of hospitalized COVID-19 patients with obesity, showing improved outcomes in patients with a history of bariatric surgery.

The obesity epidemic has plagued the US for decades, and the COVID-19 pandemic has further highlighted the vulnerabilities of patients with obesity and obesity-related comorbidities. 

Prevalence of Obesity and Severe Obesity among Adults: United States

Evidence used to update the list of underlying medical conditions that increase a person's risk of severe illness from COVID-19

Obesity in patients younger than 60 years is a risk 305 factor for COVID-19 hospital admission

high prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis

Bariatric surgery: a systematic review and meta-analysis

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

The impact of previous history of bariatric surgery on outcome of COVID-19. A nationwide medico-administrative French study

Effects of bariatric surgery on COVID-19: A multicentric study from a high incidence area

Association of prior metabolic and bariatric 325 surgery with severity of coronavirus disease 2019 (COVID-19) in patients with obesity

Outcomes and mortality among adults hospitalized with COVID-19 at US medical centers

American Society for Metabolic and Bariatric Surgery 2018 estimate of metabolic and bariatric procedures performed in the United States

Risk factors for severe outcomes 335 following 2009 influenza a (H1N1) infection: A global pooled analysis

Altered respiratory physiology in obesity

Perioperative management of obese patients

The impact of bariatric surgery on pulmonary function: A meta-analysis

COVID-19)

Increased ACE2 expression in bronchial epithelium of COPD patients who are overweight

Factors leading to high morbidity and mortality of 350

COVID-19 in patients with type 2 diabetes

The trinity of COVID-19: immunity, inflammation and intervention

Effect of bariatric surgery on serum inflammatory factors of obese patients: A systematic review and meta-analysis

American College of Surgeons

Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates

The impact of the novel coronavirus pandemic on gastrointestinal operative volume in the United States

Table 1. Summary of characteristics of obese COVID-19 Patients with vs. without a history bariatric surgery. Without a History of Bariatric Surgery (n=122,092) With a History of Bariatric Surgery (n=2,607) P-Value* Sex

Existing comorbidities, No. (%)

Other races/ethnicities listed are non-Hispanic White, Black, and Asian

Table 2. Outcomes for obese COVID-19 patients with vs. without a history of bariatric surgery

In-hospital mortality by sex, n (%) Female 6,121 of

Male

Black 2,668 of

Hispanic 2,813 of

-hospital mortality by comorbidity, n (%) Hypertension